First Time Loading...

Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 121.89 USD 0.68% Market Closed
Updated: May 9, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

-2.9B
+8%
Operating Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-692%
7 Years
-
10 Years
-
2.3B
-45%
Investing Cash Flow
Growth Rates:
1 Year
+206%
3 Years
-
5 Years
+2 236%
7 Years
-
10 Years
-
-821m
+40%
Financing Cash Flow
Growth Rates:
1 Year
+75%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Moderna Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
(328)
(266)
(281)
(385)
(446)
(490)
(533)
(514)
(505)
(487)
(598)
(747)
598
3 495
7 062
12 202
14 638
14 055
11 765
8 362
4 784
1 207
(3 466)
(4 714)
(5 968)
Depreciation & Amortization
26
23
24
25
27
29
29
31
31
31
33
31
39
100
161
232
296
303
346
348
347
363
499
621
579
Change in Deffered Taxes
0
0
0
0
0
0
0
0
0
0
0
0
(50)
(72)
(89)
(318)
(414)
(622)
(702)
(559)
(723)
(713)
848
828
1 138
Stock-Based Compensation
52
66
81
73
79
86
92
81
83
86
87
93
103
113
131
142
156
171
201
226
257
281
288
305
0
Other Non-Cash Items
53
47
51
72
78
84
89
78
81
87
94
166
180
197
231
196
223
256
293
285
303
238
276
286
296
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
480
0
0
0
2 729
0
0
0
(357)
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
9
0
0
0
14
0
0
0
25
0
0
0
39
0
Change in Working Capital
(193)
(108)
(135)
(43)
(24)
(48)
(38)
(54)
(27)
33
1 136
2 577
4 337
5 471
4 209
1 308
(1 331)
(4 339)
(5 073)
(3 455)
(3 718)
(1 321)
(235)
(139)
1 073
Cash from Operating Activities
(442)
N/A
(305)
+31%
(342)
-12%
(331)
+3%
(364)
-10%
(424)
-16%
(451)
-6%
(459)
-2%
(421)
+8%
(336)
+20%
664
N/A
2 027
+205%
5 104
+152%
9 191
+80%
11 574
+26%
13 620
+18%
13 412
-2%
9 653
-28%
6 629
-31%
4 981
-25%
993
-80%
(226)
N/A
(2 078)
-819%
(3 118)
-50%
(2 882)
+8%
Investing Cash Flow
Capital Expenditures
(90)
(107)
(104)
(106)
(82)
(58)
(39)
(32)
(30)
(39)
(51)
(67)
(96)
(107)
(187)
(284)
(381)
(438)
(428)
(400)
(381)
(528)
(579)
(707)
(790)
Other Items
24
(259)
(161)
(267)
181
(78)
(100)
17
(289)
(22)
(1 301)
(1 604)
(1 439)
(5 318)
(7 387)
(8 239)
(11 883)
(9 100)
(4 838)
(4 776)
1 137
4 380
4 275
4 913
3 103
Cash from Investing Activities
(67)
N/A
(367)
-448%
(265)
+28%
(373)
-41%
99
N/A
(137)
N/A
(139)
-1%
(15)
+89%
(319)
-2 027%
(60)
+81%
(1 352)
-2 153%
(1 672)
-24%
(1 536)
+8%
(5 426)
-253%
(7 575)
-40%
(8 523)
-13%
(12 264)
-44%
(9 538)
+22%
(5 266)
+45%
(5 176)
+2%
756
N/A
3 852
+410%
3 696
-4%
4 206
+14%
2 313
-45%
Financing Cash Flow
Net Issuance of Common Stock
550
661
653
1 217
667
560
584
50
628
2 005
2 019
2 039
1 489
144
146
(733)
(1 372)
(2 689)
(3 716)
(3 264)
(3 170)
(2 501)
(1 499)
(1 107)
(575)
Net Issuance of Debt
(2)
(4)
(5)
(2)
(1)
1
3
0
0
0
(1)
(6)
(8)
(68)
(102)
(140)
(169)
(155)
(167)
(184)
(178)
(188)
(207)
(270)
(246)
Other
3
4
4
12
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
550
N/A
661
+20%
652
-1%
1 227
+88%
677
-45%
571
-16%
596
+4%
51
-91%
629
+1 133%
2 006
+219%
2 020
+1%
2 033
+1%
1 481
-27%
76
-95%
44
-42%
(873)
N/A
(1 541)
-77%
(2 844)
-85%
(3 883)
-37%
(3 448)
+11%
(3 348)
+3%
(2 689)
+20%
(1 706)
+37%
(1 377)
+19%
(821)
+40%
Change in Cash
Net Change in Cash
41
N/A
(11)
N/A
45
N/A
523
+1 062%
412
-21%
10
-98%
6
-40%
(423)
N/A
(111)
+74%
1 610
N/A
1 332
-17%
2 388
+79%
5 049
+111%
3 841
-24%
4 043
+5%
4 224
+4%
(393)
N/A
(2 729)
-594%
(2 520)
+8%
(3 643)
-45%
(1 599)
+56%
937
N/A
(88)
N/A
(289)
-228%
(1 390)
-381%
Free Cash Flow
Free Cash Flow
(532)
N/A
(412)
+23%
(446)
-8%
(437)
+2%
(446)
-2%
(482)
-8%
(490)
-2%
(491)
0%
(451)
+8%
(375)
+17%
613
N/A
1 960
+220%
5 008
+156%
9 084
+81%
11 387
+25%
13 336
+17%
13 031
-2%
9 215
-29%
6 201
-33%
4 581
-26%
612
-87%
(754)
N/A
(2 657)
-252%
(3 825)
-44%
(3 672)
+4%

See Also

Summary
MRNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRNA stock valuation using valuation multiples.
Wall Street Estimates
MRNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.